Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry

Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry

Acetylsalicylic acid (ASA), also known as aspirin, appears to be ineffective in inhibiting platelet aggregation in 20–30% of patients. Light transmission aggregometry (LTA) is a gold standard platelet function assay. In this pilot study, we used LTA to personalize ASA therapy ex vivo in atherosclero...

Full description

Bibliographic Details
Main Authors:	Hamzah Khan, Reid C. Gallant, Abdelrahman Zamzam, Shubha Jain, Sherri Afxentiou, Muzammil Syed, Zachary Kroezen, Meera Shanmuganathan, Philip Britz-McKibbin, Margaret L. Rand, Heyu Ni, Mohammed Al-Omran, Mohammad Qadura
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Diagnostics
Subjects:	aspirin light transmission aggregometry non-sensitivity personalized medicine atherosclerosis anti-platelet
Online Access:	https://www.mdpi.com/2075-4418/10/11/871

Similar Items

Plateletworks<sup>®</sup> as a Point-of-Care Test for ASA Non-Sensitivity
by: Hamzah Khan, et al.
Published: (2021-08-01)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
by: Hamzah Khan, et al.
Published: (2021-12-01)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
by: Hamzah Khan, et al.
Published: (2020-10-01)

Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry
by: Overbeck Ursula, et al.
Published: (2011-04-01)

96-well plate-based aggregometry
by: Melissa V. Chan, et al.
Published: (2018-10-01)

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms
by: Andréas Perrier-Cornet, et al.
Published: (2018-10-01)

How to perform aggregometry and lumi-aggregometry in mouse platelets
by: Craig E. Hughes
Published: (2018-10-01)

Comparison of antiplatelet activity of garlic tablets with cardio-protective dose of aspirin in healthy volunteers: a randomized clinical trial
by: Mojtaba Shafiekhani, et al.
Published: (2016-08-01)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
by: Hamzah Khan, et al.
Published: (2022-08-01)

Platelet function testing in cardiac surgery: A comparative study of electrical impedance aggregometry and thromboelastography
by: Bilal H. Kirmani, et al.
Published: (2017-08-01)

Advances in Platelet Function Testing—Light Transmission Aggregometry and Beyond
by: Jessica Le Blanc, et al.
Published: (2020-08-01)

Optimized tool for evaluation of platelet function measured by impedance aggregometry
by: Anna Schultz-Lebahn, et al.
Published: (2021-08-01)

Assessment of light transmission aggregometry on the routine coagulation analyzer Sysmex CS-2500 using CE-marked agonists from Hyphen Biomed
by: V.-E. Bret, et al.
Published: (2019-05-01)

Hirudin versus citrate as an anticoagulant for ROTEM platelet whole blood impedance aggregometry in thrombocytopenic patients
by: Wasanthi Wickramasinghe, et al.
Published: (2023-12-01)

Automated Light Transmission Aggregometry with and without Platelet Poor Plasma Reference: A Method Comparison
by: Ulrich J. Sachs, et al.
Published: (2023-01-01)

Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate<sup>®</sup> Analyzer and Serum Thromboxane B<sub>2</sub>
by: Weiwei Zeng, et al.
Published: (2022-10-01)

Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline
by: I.C.A. Munnix, et al.
Published: (2021-05-01)

Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein‐losing nephropathy
by: Sarah Shropshire, et al.
Published: (2020-03-01)

Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
by: Rafiq Sulman, et al.
Published: (2012-04-01)

Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin
by: Marco Tescione, et al.
Published: (2021-03-01)

Point-of-care HEMOstasis in children with congenital heart disease, the POCHEMO study: Rotational thromboelastometry and impedance aggregometry in children with cyanotic and non-cyanotic congenital heart disease
by: Marie-Hélène Perez, et al.
Published: (2022-06-01)

Effects of Time-Interval since Blood Draw and of Anticoagulation on Platelet Testing (Count, Indices and Impedance Aggregometry): A Systematic Study with Blood from Healthy Volunteers
by: Michael Hardy, et al.
Published: (2020-08-01)

TEG Platelet Mapping and Impedance Aggregometry to Predict Platelet Transfusion During Cardiopulmonary Bypass in Pediatric Patients
by: Erin E. Barker, et al.
Published: (2019-12-01)

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry
by: Kevin P. Bliden, et al.
Published: (2024-12-01)

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
by: Hamzah Khan, et al.
Published: (2022-09-01)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Diona Gjermeni, et al.
Published: (2022-07-01)

Aspirin: yesterday, today, and tomorrow
by: Marina Nikołajewna Dołżenko
Published: (2014-06-01)

Aspirin : the miracle drug /
by: 296334 Metcalf, Eric
Published: (2005)

The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function
by: Gerhardus J. A. J. M. Kuiper, et al.
Published: (2017-10-01)

Recovery Time of Platelet Function After Aspirin Withdrawal
by: Jeonghun Lee, MD, et al.
Published: (2014-12-01)

Comparative antinociceptive effect of aspirin and aspirin nano particles in semisolid formulae in mice
by: Labeeb H. Al- Alsadoon, et al.
Published: (2021-04-01)

Aspirin tablets
by: 982 SIRIM

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
by: Sandi M. Azab, et al.
Published: (2020-06-01)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
by: Nischal N Hegde, et al.
Published: (2023-01-01)

A Sticky Situation: Variable Agreement Between Platelet Function Tests Used to Assess Anti-platelet Therapy Response
by: Hirotomo Nakahara, et al.
Published: (2022-07-01)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
by: Lucyna Mastalerz, et al.
Published: (2021-08-01)

Aspirin in dermatology: Revisited
by: Aditya Kumar Bubna
Published: (2015-01-01)

Aspirin-Exacerbated Asthma
by: Varghese Mathew, et al.
Published: (2008-06-01)

A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization
by: Hossein Esmaeilzadeh, et al.
Published: (2022-10-01)

Validation of Plateletworks ADP for the ProCyte Dx analyzer
by: Matthew R. Kornya, et al.
Published: (2023-03-01)